∧ ∨ Type | ∧ ∨ Title | Principal Investigators | Status | ∧ ∨ Year |
---|---|---|---|---|
PRIN2022 - PRIN bando 2022 |
Toward a green toxicology: new approach methodologies to screen chemical-induced immunotoxicity (GREENTOX)
|
|
Ongoing | 2023 |
PRIN2022 - PRIN bando 2022 |
Dissecting the pharmacological mechanisms underlying the therapeutic potential of phytocannabinoids in autism
|
|
Ongoing | 2023 |
PRIN2022 - PRIN bando 2022 |
The role of TRPM8 and its dietary ligands in intestinal fibrosis: a translational exploration
|
|
Ongoing | 2023 |
PRIN2022 - PRIN bando 2022 |
DEVELOPMENTAL ROLE OF THE MUTANT ANDROGEN RECEPTOR CAUSATIVE OF SPINAL AND BULBAR MUSCULAR ATROPHY (SBMA)
|
|
Ongoing | 2023 |
PRIN2022 - PRIN bando 2022 |
STRESS AND PSYCHOPATHOLOGIC DOMAINS: FROM MOLECULAR MECHANISMS TO BRAIN CIRCUITS
|
|
Ongoing | 2023 |
PRIN2022 - PRIN bando 2022 |
Supporting medication adherence by the Elderly: development of an action framework for different healthcare settings
|
|
Ongoing | 2023 |
PRIN2022 - PRIN bando 2022 |
PAtient Lipidome As biomarker of Cancer immunothErapy (PALACE study)
|
|
Ongoing | 2023 |
PRIN2022 - PRIN bando 2022 |
Evaluation of Castanea sativa by-products as a source of bioactive molecules against Helicobacter pylori-induced inflammation: a novel sustainable strategy Acronym: CastACTIVE
|
|
Ongoing | 2023 |
PRIN2022 - PRIN bando 2022 |
Adoptive cell transfer of metabolic reprogrammed T regulatory cells to control atherosclerosis progression and to prevent end organ damage in cardiovascular disease.
|
|
Ongoing | 2023 |
PRIN2022 - PRIN bando 2022 |
Pharmacological inhibition and genetic deletion of PCSK9: in vitro and in vivo studies on smooth muscle cell aortic calcification
|
|
Ongoing | 2023 |